Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Paolo Dessanti"'
Autor:
Isabella Ricci, Francesco Barillaro, Enrico Conti, Donatella Intersimone, Paolo Dessanti, Carlo Aschele
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 93, Iss 1 (2021)
Renal cell carcinoma (RCC) is known to cause metastasis to unusual sites, which can be both synchronous or metachronous. Thyroid gland is a rare site for metastasis. However, RCC is the most common primary neoplasm to metastasize to the Thyroid gland
Externí odkaz:
https://doaj.org/article/675899871e044ae4901112e3b23afd25
Autor:
Francesco Barillaro, Marco Camilli, Paolo Dessanti, Nader Gorji, Fabio Chiesa, Alessandro Villa, Alessandro Pastorino, Carlo Aschele, Enrico Conti
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 90, Iss 3, Pp 224-226 (2018)
Skin melanoma represents one of the most common and lethal solid tumor. It usually develops on the skin but it can occur in any tissues with melanine- containing-cells (extracutaneous malignant melanoma). Only 4-5% of malignant melanomas originate in
Externí odkaz:
https://doaj.org/article/5d3eead78abd4833a5dffdd77b3b2803
Autor:
Pier Aldo Canessa, Paola Ferro, Beatrice Dozin, Silvio Roncella, Silvano Ferrini, Grazia Carbotti, Paolo Dessanti, Marina Fabbi
Publikováno v:
Cancer Immunology, Immunotherapy. 70:3349-3355
Literature reports suggest that the host immune system may control Malignant Pleural Mesothelioma (MPM) growth, although its activity is limited by regulatory mechanisms. In this retrospective study, we analyzed the levels of pro-inflammatory (IL-1,
Autor:
Ugo Giannoni, Maria Pia Pistillo, Vincenzo Fontana, Antonella Vigani, Marika Tonarelli, Paolo Dessanti, Giovanni Berisso, Paola Ferro, Cristiana Rossi, Pier Aldo Canessa, Roberta Carosio, Silvio Roncella, Maria Cristiana Franceschini
Publikováno v:
Anticancer Research. 39:5219-5223
AIM This study evaluated the prognostic value of soluble mesothelin-related protein (SMRP) levels in pleural effusions (PE) from patients with pleural mesothelioma (MPM). PATIENTS AND METHODS SMRP level in PE was tested using an enzyme-linked immunos
Autor:
Maria Cristiana Franceschini, Giovanni Berisso, Paola Ferro, Paolo Dessanti, Pier Aldo Canessa, Antonella Vigani, Roberta Carosio, Maria Pia Pistillo, Vincenzo Fontana, Marika Tonarelli, Ugo Giannoni, Silvio Roncella
Publikováno v:
Oncol Lett
Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor survival rates. Therefore, it is essential to have effective biological markers predicting the course of the disease and prognosis. The aim of the present study was to highlight th
Autor:
Massimo D’Amato, Alice Ferrari, Michele Moroni, Paolo Dessanti, Nicola Romano, Teseo Stefanini, Alex Bardine
Publikováno v:
Ear, nose,throat journal. 101(7)
Autor:
Roberta Carosio, Antonella Vigani, Luca Mastracci, Paolo Dessanti, Paola Ferro, Barbara Banelli, Pier Aldo Canessa, Anna Morabito, Maria Pia Pistillo, Vincenzo Fontana, Federica Grillo, Silvio Roncella, Ulrich Pfeffer, Alessandro Poggi
Publikováno v:
Journal of cancer research and clinical oncology. 147(2)
Programmed death-ligand 1 (PD-L1) protein plays a central role in the antitumor immune response, and appears to be a predictor of prognosis and efficacy for PD-L1 and programmed death 1 (PD-1) blockade therapy. The immunoregulatory role and prognosti
Autor:
Donatella Intersimone, Francesco Barillaro, Carlo Aschele, Enrico Conti, Paolo Dessanti, Isabella Ricci
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 93, Iss 1 (2021)
Renal cell carcinoma (RCC) is known to cause metastasis to unusual sites, which can be both synchronous or metachronous. Thyroid gland is a rare site for metastasis. However, RCC is the most common primary neoplasm to metastasize to the Thyroid gland
Autor:
Paolo Dessanti, Silvio Roncella, Valentina Pinelli, Enrico Battolla, Anna Morabito, Franco Fedeli, Maria Cristiana Franceschini, Pier Aldo Canessa, Maria Pia Pistillo, Paola Ferro, Vincenzo Fontana
Publikováno v:
Anticancer Research. 37:1387-1392
BACKGROUND In the literature, there exist conflicting data on the value of fibulin-3 (FBLN3) for the diagnosis of pleural effusion (PE) in malignant pleural mesothelioma (MPM). Therefore we compared the diagnostic performance of FBLN3 against that of
Autor:
Isabella Ricci, Francesco Barillaro, Enrico Conti, Donatella Intersimone3, Paolo Dessanti, Carlo Aschele
Publikováno v:
Journal of Medical Research and Surgery. 1:1-1
No Abstract in Short Communication.